| Treatment of substance use disorders among women of reproductive age by depression and anxiety disorder status, 2008–2014 J Zhou, JY Ko, SC Haight, VT Tong Journal of Women's Health 28 (8), 1068-1076, 2019 | 47 | 2019 |
| Association of fluoroquinolone prescribing rates with black box warnings from the US food and drug administration A Sankar, KM Swanson, J Zhou, AB Jena, JS Ross, ND Shah, ... JAMA Network Open 4 (12), e2136662-e2136662, 2021 | 24 | 2021 |
| Early mortality after inpatient versus outpatient catheter ablation in patients with atrial fibrillation MJ Obeid, J Zhou, AJ Sale, C Longacre, EP Zeitler, J Andrade, S Mittal, ... Heart Rhythm 20 (6), 833-841, 2023 | 4 | 2023 |
| Utilization of remote reprogramming to manage insertable cardiac monitor arrhythmia alert burden A Seiler, S Rosemas, J Zhou, J Rogers Cardiovascular Digital Health Journal 3 (4), S23-S24, 2022 | 2 | 2022 |
| Impact of Atrial Fibrillation Burden on Health Care Costs and Utilization G Peigh, J Zhou, SC Rosemas, AI Roberts, C Longacre, T Nayak, ... JACC: Clinical Electrophysiology, 2024 | 1 | 2024 |
| DEVICE-DETECTED ATRIAL FIBRILLATION AND HEALTHCARE UTILIZATION FOR STROKE AND HEART FAILURE G Peigh, J Zhou, A Roberts, S Rosemas, C Longacre, D Soderlund, ... Journal of the American College of Cardiology 83 (13_Supplement), 160-160, 2024 | | 2024 |
| Utilization of remote reprogramming to manage insertable cardiac monitor arrhythmia alert burden A Seiler, S Rosemas, J Zhou, N Franco, J Rogers Journal of Cardiovascular Electrophysiology 35 (2), 341-345, 2024 | | 2024 |
| Association of atrial fibrillation burden with rhythm control and stroke prevention interventions among patients with cardiac implantable electronic devices G Peigh, J Zhou, AI Roberts, SC Rosemas, C Longacre, G Schwab, ... European Heart Journal 44 (Supplement_2), ehad655. 434, 2023 | | 2023 |
| A large, real-world cohort analysis of arrhythmia detections with insertable cardiac monitors S Saha, J Zhou, SC Rosemas, V Ramos, AP Radtke, S Majumder, ... European Heart Journal 44 (Supplement_2), ehad655. 309, 2023 | | 2023 |
| Mechanisms for increased healthcare expenditures among patients with device detected atrial fibrillation G Peigh, J Zhou, AI Roberts, SC Rosemas, C Longacre, G Schwab, ... Europace 25 (Supplement_1), euad122. 020, 2023 | | 2023 |
| Association between atrial fibrillation and healthcare costs among patients with cardiac implantable electronic devices G Peigh, J Zhou, AI Roberts, SC Rosemas, C Longacre, G Schwab, ... Europace 25 (Supplement_1), euad122. 019, 2023 | | 2023 |
| PO-03-154 AN ANALYSIS OF THE PATIENT-INCURRED COSTS ASSOCIATED WITH DEVICE-DETECTED ATRIAL FIBRILLATION G Peigh, J Zhou, AI Roberts, S Rosemas, C Longacre, G Schwab, ... Heart Rhythm 20 (5), S414, 2023 | | 2023 |
| PO-05-166 ASSOCIATIONS BETWEEN DEVICE DETECTED ATRIAL FIBRILLATION AND MORTALITY AMONG PATIENTS WITH CARDIAC IMPLANTABLE ELECTRONIC DEVICES G Peigh, J Zhou, AI Roberts, S Rosemas, C Longacre, G Schwab, ... Heart Rhythm 20 (5), S661, 2023 | | 2023 |
| IMPACT OF ACCESS TO CARE ON RACIAL DISPARITIES IN RATES OF CARDIAC DEVICE IMPLANTATIONS A Ahmed, A Marti, D Soderlund, J Zhou, AB Curtis Journal of the American College of Cardiology 81 (8_Supplement), 228-228, 2023 | | 2023 |
| Association Between use of an Adaptive Cardiac Resynchronization Therapy Algorithm and Healthcare Utilization and Cost MR Gold, J Zhou, L Higuera, D Lanctin, E Chung medRxiv, 2023.12. 08.23299751, 2023 | | 2023 |
| Uptake of evidence by physicians: De-adoption of erythropoiesis-stimulating agents after the TREAT trial K Vu, J Zhou, A Everhart, N Desai, J Herrin, AB Jena, JS Ross, ND Shah, ... BMC nephrology 22 (1), 284, 2021 | | 2021 |
| Positive Externalities of Accountable Care Organization Incentives on Peer Physicians’ Treatment Practices: Evidence from the De-Adoption of Fluoroquinolone C Stecher, J Zhou, A Sankar, P Karaca-Mandic 10th Annual Conference of the American Society of Health Economists, 2021 | | 2021 |
| Real World Comparison of Economic Outcomes between Patients with Adaptivcrt and Conventional CRT J Zhou, X Lu 2021 Virtual Annual Research Meeting, 2021 | | 2021 |
| The Economic Burden of Extended—Release Pharmaceuticals in Minnesota J Zhou, A Everhart, L Smith, Y Qiu, Y Zhu Public Health Review 3 (2), 2020 | | 2020 |
| De-Adoption of Fluoroquinolone: Evaluation of Prescribing Trends after FDA Warns of Permanent Nerve Damage Risk to Patients A Alpert, A Sankar, K Swanson, J Zhou, A Jena, JS Ross, N Shah, ... 9th Annual Conference of the American Society of Health Economists, 2020 | | 2020 |
Pinar Karaca MandicUniversity of Minnesota and NBERVerified email at umn.edu
